TELOMIR-OTC Trademark

Trademark Overview


On Monday, January 8, 2024, a trademark application was filed for TELOMIR-OTC with the United States Patent and Trademark Office. The USPTO has given the TELOMIR-OTC trademark a serial number of 98346717. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, August 22, 2024. This trademark is owned by Miralogx LLC. The TELOMIR-OTC trademark is filed in the Pharmaceutical Products category with the following description:

Over-the-counter preparation for skincare
telomir-otc

General Information


Serial Number98346717
Word MarkTELOMIR-OTC
Filing DateMonday, January 8, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, August 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesOver-the-counter preparation for skincare
Pseudo MarkTELOMERE OTC

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMiralogx LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTampa, FL 33606

Trademark Events


Event DateEvent Description
Monday, January 8, 2024NEW APPLICATION ENTERED
Thursday, April 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 3, 2024ASSIGNED TO EXAMINER
Thursday, August 22, 2024NON-FINAL ACTION E-MAILED
Thursday, August 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 22, 2024NON-FINAL ACTION WRITTEN